BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36156392)

  • 1. Newborn screening for Fabry disease in Oregon: Approaching the iceberg of A143T and variants of uncertain significance.
    Viall S; Dennis A; Yang A
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):206-214. PubMed ID: 36156392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for Fabry disease in the north-west of Spain.
    Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR
    Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychosocial Impact of Carrying a Debated Variant in the GLA Gene.
    Macklin S; Laney D; Lisi E; Atherton A; Smith E
    J Genet Couns; 2018 Feb; 27(1):217-224. PubMed ID: 28799081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of later-onset fabry disease revealed by newborn screening.
    Spada M; Pagliardini S; Yasuda M; Tukel T; Thiagarajan G; Sakuraba H; Ponzone A; Desnick RJ
    Am J Hum Genet; 2006 Jul; 79(1):31-40. PubMed ID: 16773563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience.
    Gragnaniello V; Burlina AP; Polo G; Giuliani A; Salviati L; Duro G; Cazzorla C; Rubert L; Maines E; Germain DP; Burlina AB
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34199132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
    Rosa Neto NS; Bento JCB; Pereira RMR
    Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and biological studies of α-galactosidase A variants with uncertain significance from newborn screening in Taiwan.
    Liao HC; Hsu TR; Young L; Chiang CC; Huang CK; Liu HC; Niu DM; Chen YJ
    Mol Genet Metab; 2018 Feb; 123(2):140-147. PubMed ID: 28615118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of novel Fabry disease-associated pathogenic variants in Japanese patients by newborn and high-risk screening.
    Sawada T; Kido J; Sugawara K; Matsumoto S; Takada F; Tsuboi K; Ohtake A; Endo F; Nakamura K
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1502. PubMed ID: 33016649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.
    van der Tol L; Smid BE; Poorthuis BJ; Biegstraaten M; Deprez RH; Linthorst GE; Hollak CE
    J Med Genet; 2014 Jan; 51(1):1-9. PubMed ID: 23922385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
    Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
    Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease: Review and experience during newborn screening.
    Hsu TR; Niu DM
    Trends Cardiovasc Med; 2018 May; 28(4):274-281. PubMed ID: 29100912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry disease in the Spanish population: observational study with detection of 77 patients.
    Vieitez I; Souto-Rodriguez O; Fernandez-Mosquera L; San Millan B; Teijeira S; Fernandez-Martin J; Martinez-Sanchez F; Aldamiz-Echevarria LJ; Lopez-Rodriguez M; Navarro C; Ortolano S
    Orphanet J Rare Dis; 2018 Apr; 13(1):52. PubMed ID: 29631605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
    Lenders M; Weidemann F; Kurschat C; Canaan-Kühl S; Duning T; Stypmann J; Schmitz B; Reiermann S; Krämer J; Blaschke D; Wanner C; Brand SM; Brand E
    Orphanet J Rare Dis; 2016 May; 11(1):54. PubMed ID: 27142856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.
    Lin HY; Chong KW; Hsu JH; Yu HC; Shih CC; Huang CH; Lin SJ; Chen CH; Chiang CC; Ho HJ; Lee PC; Kao CH; Cheng KH; Hsueh C; Niu DM
    Circ Cardiovasc Genet; 2009 Oct; 2(5):450-6. PubMed ID: 20031620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparision of fluorimetric and mass spectrometric methods for Fabry disease newborn screening.
    Orlov DS; Nazarenko LP; Didenko LI; Seitova GN
    Klin Lab Diagn; 2022 Apr; 67(4):204-206. PubMed ID: 35575392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of newborn screening for six lysosomal diseases in Brazil.
    Kubaski F; Sousa I; Amorim T; Pereira D; Silva C; Chaves V; Brusius-Facchin AC; Netto ABO; Soares J; Vairo F; Poletto E; Trometer J; Souza A; Ranieri E; Polo G; Hong X; Herbst ZM; Burlina A; Gelb MH; Giugliani R
    Mol Genet Metab; 2023; 140(1-2):107654. PubMed ID: 37507255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
    Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
    Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations.
    Chien YH; Lee NC; Chiang SC; Desnick RJ; Hwu WL
    Mol Med; 2012 Jul; 18(1):780-4. PubMed ID: 22437327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
    De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.